semaglutide shortage list and Tirzepatide off FDA list: What does this mean for weight loss drug access? The Wegovy Shortage Continues, Leaving

Intracranial metastasis of MPNST is a hallmark of advanced disease, associated with a median survival of less than five months

Are new oral GLP-1 drugs expected to launch soon

Patients with Pre-diabetes/High A1C: Given its powerful dual action on glucose control, it is an ideal choice for reversing metabolic damage tied to high blood sugar

But how the drug is acting is always a black box a super black box in this case, Moss says

In China, by June 2025, there were already 17 candidates running Phase III clinical trials or already in the pre-market application stage, while in India over 10 companies had submitted requests to the Subject Expert Committee (SEC) to conduct Phase III studies for semaglutide, with 7 of them focusing on oral semaglutide